Mol. Immunol.
Comparative analysis of two HIV-1 multiepitope polypeptides for stimulation of immune responses in BALB/c mice.
Kardani K, Hashemi A, Bolhassani A
A licensed vaccine against human immunodeficiency virus-1 (HIV-1) infection has not become available up to now. Hence, it is more rational to use immu ...
Read More
Source: PubMed
Med Clin (Barc) 2020 Jan 28
Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus.
Cañas-Ruano E, Martín-Castillo M, Raventós B, Burgos J, Curran A, Navarro J, García J, Suanzes P, Ribera E, Falcó V
A higher incidence of malignancies has been described in patients with HIV infection compared to the general population. ...
Read More
Source: PubMed
Int. J. Tuberc. Lung Dis.
Multidrug-resistant tuberculosis in the United States, 2011-2016: patient characteristics and risk factors.
Chen MP, Miramontes R, Kammerer JS
OBJECTIVE: To determine risk factors for multidrug-resistant tuberculosis (MDR-TB) and describe MDR-TB according to three characteristics: previous TB ...
Read More
Source: PubMed
Reprod Health
Strategies to facilitate safe sexual practices in adolescents through integrated health systems in selected districts of Zimbabwe: a mixed method study protocol.
Nunu WN, Makhado L, Mabunda JT, Lebese RT
Zimbabwe has the highest teenage pregnancy rate in Sub Saharan Africa. Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS ...
Read More
Source: PubMed
BMC Public Health
Prevalence and determinants of recent HIV testing among older persons in rural Uganda: a cross-sectional study.
Wandera SO, Kwagala B, Maniragaba F
There is limited research on HIV testing among older persons in Uganda. The aim of this study was to investigate the socio-demographic determinants of ...
Read More
Source: PubMed
